Clinical Trial Update: Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses safety and immunological response to a boosting dose of MVA-B in healthy volunteers who previously received MVA-B four years earlier…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MVA-B

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: HIV Infections | Phase 1 | Status: COMPLETED